The University of Arizona Cancer Center welcomes new faculty members to the Section of Hematology/Oncology and the Department of Radiation Oncology in the UA College of Medicine.
Faiz Anwer, MD, an assistant professor of medicine, returned to the UA after completing about nine months in specialized blood and marrow transplantation (BMT) training at the Seattle Cancer Care Alliance. His primary clinical focus is on bone marrow transplantation, and he also practices malignant hematology. He is board certified in internal medicine and medical oncology. Dr. Anwer is responsible for the portfolio of Adult Hematology and BMT clinical research studies, in collaboration with Andrew Yeager, MD, and other faculty members. He received his graduate and post graduate medical training at the Rawalpindi Medical College, University of the Punjab, Pakistan; and further residency training at University of Pittsburgh Medical Center McKeesport and completed a fellowship in hematology/oncology at the UA.
Pavani Chalasani, MD, MPH, an assistant professor of medicine, was the UACC’s chief fellow. Her primary focus is breast cancer medical oncology and benign hematology. She has a strong interest in translational research, with plans to develop a number of studies, and will mentor with Robert Livingston, MD, and Alison Stopeck, MD. Dr. Chalasani received her medical degree at Gandhi Medical College, Hyderabad, India, and a master’s degree in public health from the University of Massachusetts. She completed her residency at the UA. She is board certified in internal medicine.
Hitendra Patel, MD, is an assistant professor of medicine with a primary focus in GI medical oncology. He spent six years at the Truman Medical Center of the University of Missouri in Kansas City. Dr. Patel completed his hematology-oncology fellowship at the University of Pittsburgh, where he worked with Dr. Yeager.
Soham Puvvada, MD, an assistant professor of medicine, joins the UA after completing a fellowship at Duke University Medical Center. Her primary focus is lymphoid malignancies and translational research. Her prior research has been in translational genomics, pathway analysis and preclinical drug discovery and development. She is a recipient of the competitive American Society of Hematology CRTI Career Development Award as well as Duke Silber Memorial Research Award. Dr. Puvvada received her medical degree at the University of South Florida College of Medicine and completed her internal medicine residency at the University of North Carolina Chapel Hill. She is board certified in internal medicine and board eligible for hematology oncology. She was recruited to join the UACC's Lymphoma Program under the guidance and mentorship of Thomas P. Miller, MD, who is a world-renowned authority on lymphoma.
Jonathan Schatz, MD, an assistant professor of medicine, completed his hematology-oncology fellowship at Memorial Sloan-Kettering Cancer Center and has been pursuing a laboratory-based career in molecular-targeted therapeutics, with an emphasis on lymphoma. He was recruited for a highly competitive Clinical Translational Science Institute (CTSI) position in collaboration with BIO5. His clinical focus is Hodgkin and non-Hodgkin lymphoma.
Parminder Singh, MD, is an assistant professor and joins the faculty after completing residency and a hematology-oncology fellowship at New York Medical College, Westchester Medical Center where he was the chief fellow. Dr. Singh’s primary focus is in genitourinary medical oncology. His key area of interest is developing new drugs in kidney and prostate cancer. Dr. Singh will also focus on developing studies to elucidate new biomarkers in prostate and kidney cancer. He will mentor with Frederick Ahmann, MD, and Evan Hersh, MD. He received his medical degree from Maulana Azad Medical College in New Delhi, India.
Krisha Howell, MD, an assistant professor, joins the Radiation Oncology Department from the Princess Margaret Hospital/University of Toronto where she completed a fellowship in brachytherapy and specialized in genitourinary/gynecological cancers. She received her medical degree from Wayne State University, served an internship in internal medicine at UA and completed radiation oncology residency at the Medical University of South Carolina at Charleston. Her clinical specialties are in gastrointestinal malignancies, sarcoma and metastatic cancer.
Sun Yi, MD, an assistant professor, joins the Radiation Oncology Department from the University of California, Davis, Comprehensive Cancer Center. He earned his medical degree from Boston University School of Medicine. Dr. Yi specializes in treating patients with head-and-neck cancer in a multidisciplinary setting with the most advanced techniques including Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy.
Oct. 18, 2012
